PROVIDER PROFILE · NPI 1033370986
Nnamdi EzeMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,076
Unique beneficiaries
—
Total services
89,565
Distinct HCPCS
57
Medicare payment
$984K
Peer benchmark
Total Medicare services vs. 206 Hematology-Oncology providers in TN — top quintile (cohort median 1,775).
PRESCRIBING · PART D · 2024
Total Rx claims
678
Beneficiaries
—
Total drug cost
$2.7M
Distinct drugs
24
Brand share
35.5%
Top prescribed drugs
Anastrozole74 claims
Lenalidomide69 claims
Hydroxyurea67 claims
Letrozole45 claims
Warfarin Sodium42 claims
QUALITY · MIPS · 2024
Final MIPS score
92.7
Quality
3.6
Cost
70.8
Improvement activities
40.0
Promoting interop.
89.0
Payment adjustment
0.75%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$1K
Payment records
63
By payment type
Food and Beverage$1K
Education$17
Top paying entities
Food and Beverage$1K
Education$17
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
REFERRAL NETWORK
Where Nnamdi Eze's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| YALE NEW HAVEN HOSPITAL | 26 | 126 |
| Jill Lacy Medical Oncology · New Haven, CT | 14 | 57 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE